By Cort Johnson in Simmaron Research.
Inflammation is a big deal in the medical world. Even mild inflammation, if it’s consistently present, is known to increase one’s risk of getting cardiovascular diseases, diabetes, Alzheimer’s and many others. Standard tests for inflammation such as C-reactive protein or cholesterol, however, are often unrevealing. For instance, inflammation is a key driver of heart disease, but the first sign for many of heart problems is still a heart attack.
Likewise it’s been said that chronic fatigue syndrome (ME/CFS) and fibromyalgia (FM) are inflammatory diseases, but standard tests for inflammation often indicate that none is present. Dr. Montoya believes that current inflammation tests are missing a lot and that future tests will be able to detect the kind of inflammation occurring in ME/CFS.
Given that tests for inflammation are relatively crude, it makes sense that significant efforts would be directed to developing a better test. It’s no surprise that Mark Davis at Stanford is involved.
To read the rest of this story, click on the link below: